On August 2, 2025, New Hampshire Governor Kelly Ayotte signed two bills into law, making the state the first in New England to ban gender-affirming care for minors. House Bill 377 prohibits puberty blockers and cross-sex hormones for those under 18 when used for gender transitions, with an exception for minors already receiving these treatments to continue past the January 1, 2026, effective date. House Bill 712 bans gender-affirming breast surgeries, limiting procedures to those addressing malignancy, injury, or malformation. Violators face professional discipline, and minors can sue for damages.
Ayotte, a Republican, called the legislation a “balanced, bipartisan effort to protect children,” citing the lifelong consequences of medical decisions made at a young age. The bills, championed by Representative Lisa Mazur, garnered strong Republican support and backing from 69% of voters, per a July 2025 NH Journal poll. Supporters, including Senator Kevin Avard, argue the bans prevent irreversible harm, citing testimonies from detransitioners who regretted early interventions.
Critics, including Democratic leaders and GLBTQ Legal Advocates, argue the laws discriminate against transgender youth, potentially worsening mental health outcomes. They note that gender-affirming care, endorsed by the American Academy of Pediatrics, reduces suicide risks. Opponents warn of legal challenges, citing similar bans overturned elsewhere. Some families are reportedly planning to leave New Hampshire.
The move aligns with President Trump’s January 2025 order barring federal funding for such treatments, affecting providers nationwide. As the first Northeast state to enact these restrictions, New Hampshire’s laws intensify the national debate over transgender healthcare and parental rights.
